Cough Variant Asthma
12
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
33%
4 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (12)
Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol
Multicenter Clinical Study on the Optimal Treatment Protocol and Outcome of Cough Variant Asthma With Chinese and Western Medicine
Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma
Physiology of Cough in Asthma: Comparison of Sensory-Mechanical Responses to Mannitol and Methacholine Challenge Tests
Validity of Fractional Exhaled Nitric Oxide and Impulse Oscillometry in Patients With Cough Variant Asthma
MCT and Capsaicin Provocation Challenge in Diagnosis of Chronic Cough
The Efficacy of Budesonide/Formoterol in Cough Variant Asthma
Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules.
Acoustic Analytic Apps for Smart Telehealth Screening - Creating a Big Data
The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma
Efficacy and Safety Study of Procaterol Hydrochloride to Treat Patients With Cough Variant Asthma (CVA)
Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients